Reperfusion Injury

"Reperfusion Injury" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Adverse functional, metabolic, or structural changes in ischemic tissues resulting from the restoration of blood flow to the tissue (REPERFUSION), including swelling; HEMORRHAGE; NECROSIS; and damage from FREE RADICALS. The most common instance is MYOCARDIAL REPERFUSION INJURY.

Descriptor ID	D015427
MeSH Number(s)	C14.907.725 C23.550.767.877
Concept/Terms	Reperfusion Injury Reperfusion Injury Reperfusion Damage Damage, Reperfusion Damages, Reperfusion Reperfusion Damages Ischemia-Reperfusion Injury Ischemia Reperfusion Injury Injury, Ischemia-Reperfusion Injuries, Ischemia-Reperfusion Injury, Ischemia Reperfusion Ischemia-Reperfusion Injuries Injury, Reperfusion Injuries, Reperfusion Reperfusion Injuries

Below are MeSH descriptors whose meaning is more general than "Reperfusion Injury".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Reperfusion Injury [C14.907.725]
Pathological Conditions, Signs and Symptoms [C23]
Pathologic Processes [C23.550]
Postoperative Complications [C23.550.767]
Reperfusion Injury [C23.550.767.877]

Below are MeSH descriptors whose meaning is related to "Reperfusion Injury".

Below are MeSH descriptors whose meaning is more specific than "Reperfusion Injury".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Reperfusion Injury" by people in this website by year, and whether "Reperfusion Injury" was a major or minor topic of these publications.

Bar chart showing 54 publications over 23 distinct years, with a maximum of 9 publications in 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	1	3
1998	3	0	3
1999	1	0	1
2000	1	3	4
2001	2	0	2
2002	9	0	9
2003	1	1	2
2004	1	0	1
2005	1	0	1
2006	2	1	3
2007	2	0	2
2008	1	2	3
2009	1	3	4
2010	3	1	4
2012	2	0	2
2013	1	1	2
2014	1	0	1
2015	0	1	1
2016	1	0	1
2018	2	0	2
2019	1	0	1
2021	1	0	1
2024	0	1	1

Below are the most recent publications written about "Reperfusion Injury" by people in Profiles.

Lerchenm?ller C, Hastings MH, Rabolli CP, Betge F, Roshan M, Liu LX, Liu X, He? C, Roh JD, Platt C, Bezzerides V, Busch M, Katus HA, Frey N, Most P, Rosenzweig A. CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice. Mol Ther. 2024 10 02; 32(10):3683-3694.

View in: PubMed
Shaik NF, Regan RF, Naik UP. Platelets as drivers of ischemia/reperfusion injury after stroke. Blood Adv. 2021 03 09; 5(5):1576-1584.

View in: PubMed
Poluzzi C, Nastase MV, Zeng-Brouwers J, Roedig H, Hsieh LT, Michaelis JB, Buhl EM, Rezende F, Manavski Y, Bleich A, Boor P, Brandes RP, Pfeilschifter J, Stelzer EHK, M?nch C, Dikic I, Brandts C, Iozzo RV, Wygrecka M, Schaefer L. Biglycan evokes autophagy in macrophages via a?novel CD44/Toll-like receptor 4 signaling axis?in?ischemia/reperfusion injury. Kidney Int. 2019 03; 95(3):540-562.

View in: PubMed
Grisanti LA, Thomas TP, Carter RL, de Lucia C, Gao E, Koch WJ, Benovic JL, Tilley DG. Pepducin-mediated cardioprotection via ?-arrestin-biased ?2-adrenergic receptor-specific signaling. Theranostics. 2018; 8(17):4664-4678.

View in: PubMed
Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LT, Brandts C, Fulda S, Wygrecka M, Schaefer L. Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol. 2019 04; 77:4-22.

View in: PubMed
Kueckelhaus M, Fischer S, Sisk G, Kiwanuka H, Bueno EM, Dermietzel A, Alhefzi M, Aycart M, Diehm Y, Pomahac B. A Mobile Extracorporeal Extremity Salvage System for Replantation and Transplantation. Ann Plast Surg. 2016 Mar; 76(3):355-60.

View in: PubMed
Hsieh LT, Frey H, Nastase MV, Tredup C, Hoffmann A, Poluzzi C, Zeng-Brouwers J, Manon-Jensen T, Schr?der K, Brandes RP, Iozzo RV, Schaefer L. Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1? synthesis. Matrix Biol. 2016 Jan; 49:61-81.

View in: PubMed
Moreth K, Frey H, Hubo M, Zeng-Brouwers J, Nastase MV, Hsieh LT, Haceni R, Pfeilschifter J, Iozzo RV, Schaefer L. Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol. 2014 Apr; 35:143-51.

View in: PubMed
Mondel PK, Udare AS, Anand SV, Saraf RS, Limaye US. Recurrent cerebral hyperperfusion syndrome after intracranial angioplasty and stenting: case report with review of literature. Cardiovasc Intervent Radiol. 2014 Aug; 37(4):1087-92.

View in: PubMed
Kuczmarski JM, Martens CR, Lennon-Edwards SL, Edwards DG. Cardiac function and tolerance to ischemia-reperfusion injury in chronic kidney disease. Nephrol Dial Transplant. 2014 Aug; 29(8):1514-24.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement